Toth Financial Advisory
MDGL icon

Toth Financial Advisory’s Madrigal Pharmaceuticals MDGL Stock Holding History

Toth Financial Advisory’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.51K Sell
3
-1,997
-100% -$1.06M ﹤0.01% 846
2026
Q2 		$1.07M Hold
2,000
– – 0.1% 140
2026
Q1 		$1.05M Hold
2,000
– – 0.11% 130
2025
Q4 		$1.16M Buy
+2,000
New +$1.02M 0.13% 125
2022
Q2 		– Sell
-20
Closed -$2K – 741
2022
Q1 		$2K Buy
+20
New +$1.69K ﹤0.01% 628

Other funds holding MDGL

EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Bourgeon Capital Management
Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return
Shikiar Asset Management
Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return
Stanley-Laman Group
Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Toth Financial Advisory's MDGL Position: Q3 2026 in Review

Toth Financial Advisory reduced its Madrigal Pharmaceuticals (MDGL) stake by 100% in Q3 2026, selling an estimated $1.06M and leaving 3 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Toth Financial Advisory first reported a position in MDGL in Q1 2022 and has held it in 5 quarters since. The position peaked at $1.16M in Q4 2025. 67 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Toth Financial Advisory held 3 shares of Madrigal Pharmaceuticals worth $1.51K as of Q3 2026.
  • Toth Financial Advisory sold 1,997 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.06M.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #846 holding.
  • Toth Financial Advisory first reported a position in Madrigal Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • Toth Financial Advisory's Madrigal Pharmaceuticals position peaked at $1.16M in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.